Related Experiment Video
Updated: Feb 12, 2026

Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock
Published on: May 6, 2010
Mpox in US Immigration and Customs Enforcement Detention Facilities during 2022 Global Outbreak
Carlo Foppiano Palacios1, Mark A Travassos2
1Division of Infectious Diseases, Department of Medicine, Cooper University Healthcare and Cooper Medical School at Rowan University, Camden, New Jersey.
Abstract:
US Immigration and Customs Enforcement (ICE) detention centers are hot spots for infectious disease spread, as manifested during the COVID-19 pandemic. Mpox cases among ICE detainees during the 2022 global outbreak were investigated and a Freedom of Information Act request for mpox testing data from January to November 2022 was submitted, focusing on demographic and clinical information. Seven detainees across five facilities in Texas, Arizona, and New Jersey were tested. Two detainees tested positive, revealing a 28.6% positivity rate. One detainee received antiviral treatment. Overall, few migrant detainees have been evaluated for mpox. The limited number of mpox tests suggest that additional cases of mpox may have been missed. Adequate resources for mpox testing, treatment, and prevention within detention facilities are critical to limit spread among migrants.
Insights
Mpox testing in US Immigration and Customs Enforcement (ICE) detention centers revealed a 28.6% positivity rate among seven detainees. Limited testing may have missed additional mpox cases, highlighting the need for better resources in detention facilities.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- US Immigration and Customs Enforcement (ICE) detention centers are recognized as potential hotspots for infectious disease transmission.
- The 2022 global mpox outbreak underscored the need to monitor infectious diseases within detention settings.
Purpose of the Study:
- To investigate mpox cases among ICE detainees during the 2022 global outbreak.
- To assess the prevalence of mpox and evaluate testing and treatment practices within ICE facilities.
Main Methods:
- A Freedom of Information Act request was submitted for mpox testing data from January to November 2022.
- Data analysis focused on demographic and clinical information of tested detainees across five facilities in Texas, Arizona, and New Jersey.
Main Results:
- Seven detainees were tested for mpox across five facilities.
- Two detainees tested positive, resulting in a 28.6% positivity rate.
- One detainee received antiviral treatment; limited mpox testing suggests potential underdiagnosis.
Conclusions:
- Infectious disease surveillance and resource allocation for mpox testing, treatment, and prevention are critical in ICE detention facilities.
- Addressing the potential for missed cases is essential to control mpox spread among migrant populations.
- Enhanced public health measures are necessary to mitigate infectious disease risks within detention centers.
Related Concept Videos
Global Climate Change
Steps in Outbreak Investigation
Introduction to Global Positioning System
Errors in Global Positioning System
Global Regulatory Systems
Field Application of Global Positioning System

